Sept 20 (Reuters) - Swiss medical technology company Ypsomed YPSN.S announced on Wednesday a long-term supply deal with Novo Nordisk NOVOb.CO for autoinjectors, the latest sign of how the Danish ...
LONDON, Nov 22 (Reuters) - Swiss medical technology company Ypsomed's (YPSN.S), opens new tab contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker's ...
Lannett has entered into an agreement with Ypsomed AG, the manufacturer and supplier of the pen injector device to be used in connection with its biosimilar insulin glargine and biosimilar insulin ...
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare ...
BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced ...
Earnings call Ypsomed reported CHF 267M in core delivery systems revenue for H1 FY25/26, growing 21% YoY, with EBIT of CHF 87M and a 32.4% margin. Management reaffirmed FY guidance for ~20% revenue ...
“With STAR-0215's profile, our goal is to develop a therapy that allows patients to choose an approach that works best for their lives with the option of infrequent three- and six-month administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results